Hopp til hovedinnhold

Acanthosis nigricans

Publisert:
Sist revidert av:


Definisjon:
Hudsykdom med hyperpigmenterte områder på intertriginøse steder. Skyldes underliggende metabolske forstyrrelser, ev. arv. Kan føre til malign tilstand
Forekomst:
Økt prevalens blant ikke-hvite og ikke-asiatiske. Hyppigst blant personer under 40 år
Symptomer:
Fløyelsmyke, hyperpigmenterte plakk på huden oftest på nakken, i aksillene, i lysken. Betydelig kløe kan tyde på underliggende kreftsykdom
Funn:
Typisk foreligger intertriginøs hyperpigmentering, etter hvert verrucøse eller plakkliknende palpable forandringer
Diagnostikk:
Klinisk diagnose, ev. histologi
Behandling:
Eliminering av underliggende sykdom
  1. Brady MF, Rawla P. Acanthosis nigricans. StatPearls (Internet). Last update October 9, 2022. www.ncbi.nlm.nih.gov  
  2. Liu XK, Li J. Hyperpigmentation in the skin folds. BMJ. 2018;360:j5729. Published 2018 Jan 18. PMID: 29348270 PubMed  
  3. Yu Q, Li XL, Ji G, et al. Malignant acanthosis nigricans: an early diagnostic clue for gastric adenocarcinoma. World J Surg Oncol. 2017;15(1):208. Published 2017 Nov 25.
  4. Kong AS, Williams RL, Rhyne R, et al. Acanthosis Nigricans: high prevalence and association with diabetes in a practice-based research network consortium--a PRImary care Multi-Ethnic network (PRIME Net) study. J Am Board Fam Med. 2010;23(4):476-485. PubMed  
  5. Ng HY. Acanthosis nigricans in obese adolescents: prevalence, impact, and management challenges. Adolesc Health Med Ther. 2016;8:1-10. Published 2016 Dec 16. PMID: 28031729 PubMed  
  6. Schmidt TH, Khanijow K, Cedars MI, et al. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome. JAMA Dermatol. 2016;152(4):391-398. PubMed  
  7. Karadağ AS, You Y, Danarti R, Al-Khuzaei S, Chen W. Acanthosis nigricans and the metabolic syndrome. Clin Dermatol. 2018;36(1):48-53. PubMed  
  8. Maderal AD. Acanthosis nigricans. UpToDate, last updated Feb 03, 2023. UpToDate  
  9. Wang L, Long H, Wen H, et al. Image Gallery: Generalized mucosal and cutaneous papillomatosis, a unique sign of malignant acanthosis nigricans. Br J Dermatol 2017; 176:e99. PubMed  
  10. Patel NU, Roach C, Alinia H, Huang WW, Feldman SR. Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol. 2018;11:407-413. Published 2018 Aug 7. PMID: 30122971 PubMed  
  11. Gregoriou S, Anyfandakis V, Kontoleon P, et al. Acanthosis nigricans associated with primary hypogonadism: successful treatment with topical calcipotriol. J Dermatolog Treat. 2008;19(6):373-375. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim